Are you Dr. Feany?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# Brigham
Boston, MA 02115Phone+1 617-732-7510
Summary
- Dr. Mel Feany, MD is a board certified pathologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Brigham and Women's Hospital and is a Professor at Harvard Medical School.
Education & Training
- Brigham and Women's HospitalFellowship, Neuropathology, 1997 - 1999
- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1995 - 1999
- Albert Einstein College of MedicineClass of 1995
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MA State Medical License 1999 - 2025
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- Case Study 8: A 70-Year-Old Man With Memory Loss, Wandering, and Inappropriate Behaviors.Lakeshia C Gibson, Katherine A Krause, Seth A Gale, Barbara Schildkrout, Michael B Miller
The Journal of Neuropsychiatry and Clinical Neurosciences. 2025-01-31 - Characterization of cognitive decline in long-duration type 1 diabetes by cognitive, neuroimaging and pathological examinations.Hetal S Shah, Matthew N DeSalvo, Anastasia Haidar, Surya Vishva Teja Jangolla, Marc Gregory Yu
JCI Insight. 2025-01-30 - The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease.Matthew Torre, Camila A Zanella, Mel B Feany
The American Journal of Pathology. 2025-01-23
Press Mentions
- Cross-Species Strategy Might Be a Powerful Tool for Studying Human DiseaseFebruary 4th, 2011
- New Parkinson’s Research Center to Open at YaleNovember 4th, 2023
Grant Support
- Pharmacological Modulation Of TAU Neurotoxicity In VivoNational Institute On Aging2011
- Mechanisms Underlying Neuronal Cell Type Specificity In NeurodegenerationNational Institute On Aging2008–2011
- Chemical Modulation Of Lysosomal Storage In VivoNational Institute Of Neurological Disorders And Stroke2009–2010
- Drosophila Models Of Alexander DiseaseNational Institute Of Neurological Disorders And Stroke2008–2009
- Phosphorylation Control Of TAU Neurotoxicity In DrosophilaNational Institute On Aging2007–2008
- Aging In Drosophila Models Of Human NeurodegenerationNational Institute On Aging2006–2007
- Drosophila Model Of Amyotrophic Lateral SclerosisNational Institute Of Neurological Disorders And Stroke2004–2007
- Phosphorylation Control--Tau Neurotoxicity In DrosophilaNational Institute On Aging2004–2006
- Genetic Dissection Of Neurodegenerative DementiasNational Institute On Aging2001–2005
- Drosophila Model Of Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2001–2005
- Genetic Model Of NeurodegenerationNational Institute On Aging1998–2003